Vosevi (sofosbuvir/velpatasvir/voxilaprevir)

Many patients pay $0 through manufacturer patient assistance programs. Contact our pharmacists — we handle all the paperwork.

Vosevi is indicated for retreatment of adults with genotype 1–6 HCV infection who were previously treated with certain NS5A inhibitors, or for genotype 1a or 3 patients previously treated with sofosbuvir without an NS5A inhibitor. Taken as one pill once daily with food for 12 weeks.

This option is particularly important for patients who have failed prior HCV treatment. Our pharmacists specialize in complex HCV retreatment cases.

• For patients who failed prior HCV treatment
• Pan-genotypic retreatment option
• 12-week course, once daily with food
• Specialized retreatment pharmacist support